Eli Lillys obesity pill remains a viable rival to Novos oral Wegovy despite data that underwhelmed investors CNBC

Eli Lillys obesity pill remains a viable rival to Novos oral Wegovy despite data that underwhelmed investors  CNBC

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Eli Lilly’s stock is still recovering after the drugmaker released trial data … [+12155 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *